Key Takeaways
- Mice given psilocybin or ketamine decided more slowly but more accurately on a perceptual task
- The effect came from raised decision thresholds and a shift toward sensory-guided choices
- Orbitofrontal cortex activity reorganized under both compounds; this is an animal mechanism study, not therapy evidence
Slower, but sharper
Give a mouse a psychedelic, and it does not rush. In a study published November 20 in Science Advances, Boston University researchers found that mice given psilocybin or ketamine became slower to make decisions — but more accurate when they did.
The mice were trained on a perceptual decision-making task designed to separate choices driven by habit and bias from choices guided by the senses. After an acute dose of either compound, behavioural modelling showed the animals were raising their decision threshold — gathering more evidence before committing — and shifting toward states where they paid closer attention to sensory information.
The brain measurements matched the behaviour. Whole-brain activity mapping highlighted the orbitofrontal cortex, a region involved in weighing options, and calcium imaging showed its population activity was reorganized: neurons kept their task selectivity, but the timing and correlation patterns of their firing changed.
The authors conclude the compounds shift decision-making "toward greater reliance on sensory evidence" while reshaping cortical dynamics — a system-level account of how psychedelics change a specific mental computation.
The Twikup Take
This is a mechanism study in male mice, not a therapy trial — it says nothing directly about treating depression or PTSD in people, and the abstract reports no doses or effect sizes to weigh. What it does offer is rarer and, scientifically, more useful: a precise description of what changes in a deciding brain under these compounds. Slower and more accurate is a very different picture from the popular image of a psychedelic mind — and it is testable.
Image: Illustrative image.
